Bubby-no dilemma. Edison spruiked 2 new distribution/marketing partnership agreements by year end to bring mkt cap to $100 mil. One so far & SP down 30%. Next within 6 wks worth +$80 mil valuation....can't wait Good luck influencing mgmt. AGM was opportunity & exec decisions supported by SH vote, incl cap raise. Prepare your fury & sell orders.
Agree znew. Pipeline regardless, some of the worst mgmt performance indicators & comms in sector.
With SP tanked -55% (now 65%) & impressive destruction of SH value & mtk cap...this co mgmt then awarded CEO and CSO (ex-CEO) very large cash + options performance bonuses(!?) Taking $ off the table with short cash runway, investors hammered & need to tap mkt w/ another cap raise. Appalling & says much about "improving investor confidence/sentiment & giving something back to investors".
Best SH option now IP/pipeline buyout by well capitalised competent mgmt. If co employees assigned invention rights & co owns IP....
- Forums
- ASX - By Stock
- CMB
- Ann: Patent granted for allogeneic stem cell technology platform
Ann: Patent granted for allogeneic stem cell technology platform, page-17
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $4.235M |
Open | High | Low | Value | Volume |
35.0¢ | 35.5¢ | 35.0¢ | $233 | 662 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 128 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 1910 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 128 | 0.360 |
1 | 1327 | 0.350 |
1 | 1700 | 0.300 |
1 | 2000 | 0.290 |
1 | 2500 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 1910 | 1 |
0.450 | 6000 | 1 |
0.500 | 2135 | 2 |
0.545 | 13403 | 1 |
0.000 | 0 | 0 |
Last trade - 15.32pm 19/08/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |